Press "Enter" to skip to content

New patent expiration for Sucampo Pharma drug AMITIZA

3
Copyright © DrugPatentWatch. Originally published at New patent expiration for Sucampo Pharma drug AMITIZA

Annual Drug Patent Expirations for AMITIZA
Annual Drug Patent Expirations for AMITIZA

Amitiza is a drug marketed by Sucampo Pharma Llc and is included in one NDA. It is available from two suppliers. There are sixteen patents protecting this drug and one Paragraph IV challenge.

AMITIZA drug price trends.

Drug patent litigation for AMITIZA.

This drug has two hundred patent family members in twenty-eight countries.

The generic ingredient in AMITIZA is lubiprostone. Two suppliers are listed for this compound. Additional details are available on the lubiprostone profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Sucampo Pharma drug AMITIZA
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!